Journal article 58 views
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
Linong Ji ,
Rikke M. Agesen ,
Steve Bain ,
Fangming Fu ,
Sanaz Gabery ,
Jianlin Geng ,
Yiming Li ,
Yibing Lu,
Bifen Luo ,
Wuyan Pang,
Yi Tao ,
(for the PIONEER 12 investigators)
Diabetologia
Swansea University Author: Steve Bain
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1007/s00125-024-06133-4
Abstract
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
Published in: | Diabetologia |
---|---|
ISSN: | 0012-186X 1432-0428 |
Published: |
Springer Science and Business Media LLC
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa67081 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2024-07-12T12:36:02Z |
---|---|
last_indexed |
2024-07-12T12:36:02Z |
id |
cronfa67081 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>67081</id><entry>2024-07-12</entry><title>Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-07-12</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetologia</journal><volume/><journalNumber/><paginationStart/><paginationEnd/><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0012-186X</issnPrint><issnElectronic>1432-0428</issnElectronic><keywords/><publishedDay>0</publishedDay><publishedMonth>0</publishedMonth><publishedYear>0</publishedYear><publishedDate>0001-01-01</publishedDate><doi>10.1007/s00125-024-06133-4</doi><url>http://dx.doi.org/10.1007/s00125-024-06133-4</url><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2024-07-12T13:36:03.1159639</lastEdited><Created>2024-07-12T13:34:44.3854710</Created><path><level id="1">Swansea University Medical School</level><level id="2">Swansea University Medical School</level></path><authors><author><firstname>Linong</firstname><surname>Ji</surname><orcid>0000-0002-3262-2168</orcid><order>1</order></author><author><firstname>Rikke M.</firstname><surname>Agesen</surname><orcid>0000-0002-7649-7928</orcid><order>2</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>3</order></author><author><firstname>Fangming</firstname><surname>Fu</surname><orcid>0000-0002-0874-7526</orcid><order>4</order></author><author><firstname>Sanaz</firstname><surname>Gabery</surname><orcid>0000-0002-2243-7540</orcid><order>5</order></author><author><firstname>Jianlin</firstname><surname>Geng</surname><orcid>0009-0001-6844-9221</orcid><order>6</order></author><author><firstname>Yiming</firstname><surname>Li</surname><orcid>0000-0002-1828-8765</orcid><order>7</order></author><author><firstname>Yibing</firstname><surname>Lu</surname><order>8</order></author><author><firstname>Bifen</firstname><surname>Luo</surname><orcid>0000-0001-7166-278x</orcid><order>9</order></author><author><firstname>Wuyan</firstname><surname>Pang</surname><order>10</order></author><author><firstname>Yi</firstname><surname>Tao</surname><orcid>0009-0003-6453-5354</orcid><order>11</order></author><author><firstname>(for the PIONEER 12</firstname><surname>investigators)</surname><order>12</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
v2 67081 2024-07-12 Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2024-07-12 MEDS Journal Article Diabetologia Springer Science and Business Media LLC 0012-186X 1432-0428 0 0 0 0001-01-01 10.1007/s00125-024-06133-4 http://dx.doi.org/10.1007/s00125-024-06133-4 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2024-07-12T13:36:03.1159639 2024-07-12T13:34:44.3854710 Swansea University Medical School Swansea University Medical School Linong Ji 0000-0002-3262-2168 1 Rikke M. Agesen 0000-0002-7649-7928 2 Steve Bain 0000-0001-8519-4964 3 Fangming Fu 0000-0002-0874-7526 4 Sanaz Gabery 0000-0002-2243-7540 5 Jianlin Geng 0009-0001-6844-9221 6 Yiming Li 0000-0002-1828-8765 7 Yibing Lu 8 Bifen Luo 0000-0001-7166-278x 9 Wuyan Pang 10 Yi Tao 0009-0003-6453-5354 11 (for the PIONEER 12 investigators) 12 |
title |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial |
spellingShingle |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial Steve Bain |
title_short |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial |
title_full |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial |
title_fullStr |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial |
title_full_unstemmed |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial |
title_sort |
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial |
author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
author |
Steve Bain |
author2 |
Linong Ji Rikke M. Agesen Steve Bain Fangming Fu Sanaz Gabery Jianlin Geng Yiming Li Yibing Lu Bifen Luo Wuyan Pang Yi Tao (for the PIONEER 12 investigators) |
format |
Journal article |
container_title |
Diabetologia |
institution |
Swansea University |
issn |
0012-186X 1432-0428 |
doi_str_mv |
10.1007/s00125-024-06133-4 |
publisher |
Springer Science and Business Media LLC |
college_str |
Swansea University Medical School |
hierarchytype |
|
hierarchy_top_id |
swanseauniversitymedicalschool |
hierarchy_top_title |
Swansea University Medical School |
hierarchy_parent_id |
swanseauniversitymedicalschool |
hierarchy_parent_title |
Swansea University Medical School |
department_str |
Swansea University Medical School{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Swansea University Medical School |
url |
http://dx.doi.org/10.1007/s00125-024-06133-4 |
document_store_str |
0 |
active_str |
0 |
published_date |
0001-01-01T13:36:02Z |
_version_ |
1804376748666650624 |
score |
11.017731 |